Published in Calif Med on October 01, 1973
Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques. J Clin Invest (1973) 1.90
Thyroxine: just a prohormone or a hormone too? J Clin Endocrinol Metab (1973) 1.29
Thyroxine and triiodothyronine in the human thyroid. J Clin Endocrinol Metab (1973) 1.13
Bacterial resistance to the tetracyclines. Microbiol Rev (1978) 2.52
The tetracyclines: prospects at the beginning of the 1980s. J Antimicrob Chemother (1981) 2.33
Genetic studies of a multi-resistant strain of Staphylococcus aureus. J Med Microbiol (1974) 2.19
Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic. Biochem Biophys Res Commun (1980) 1.98
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob Agents Chemother (1998) 1.92
Molecular basis of beta-lactamase induction in bacteria. Antimicrob Agents Chemother (1993) 1.89
A variety of Staphylococcal plasmids present as multiple copies. J Gen Microbiol (1973) 1.85
Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J Gen Microbiol (1976) 1.81
Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J Gen Microbiol (1980) 1.80
Organic acids: chemistry, antibacterial activity and practical applications. Adv Microb Physiol (1991) 1.78
Mechanism of plasmic-mediated resistance to cadmium in Staphylococcus aureus. Antimicrob Agents Chemother (1975) 1.72
Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother (1991) 1.69
Transport of antibiotics into bacteria. Adv Microb Physiol (1982) 1.62
Decreased uptake of cadmium by a resistant strain of Staphylococcus aureus. J Gen Microbiol (1970) 1.60
Diffusion of tetracycline across the outer membrane of Escherichia coli K-12: involvement of protein Ia. Biochem Biophys Res Commun (1978) 1.55
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence. Antimicrob Agents Chemother (2006) 1.54
Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli. Antimicrob Agents Chemother (1992) 1.53
Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J Bacteriol (1983) 1.53
Tetracycline resistance genes from Bacillus plasmid pAB124 confer decreased accumulation of the antibiotic in Bacillus subtilis but not in Escherichia coli. J Bacteriol (1981) 1.52
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol (2007) 1.49
Reduced expression of Tn 10-mediated tetracycline resistance in Escherichia coli containing more than one copy of the transposon. J Gen Microbiol (1981) 1.48
Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother (2007) 1.48
Effect of short-chain organic acids on macromolecular synthesis in Escherichia coli. J Appl Bacteriol (1990) 1.41
Tetracycline resistance determinants from groups A to D vary in their ability to confer decreased accumulation of tetracycline derivatives by Escherichia coli. J Gen Microbiol (1982) 1.40
Antimicrobial activity and mechanisms of resistance to cephalosporin P1, an antibiotic related to fusidic acid. J Antimicrob Chemother (2002) 1.33
Leakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide. Antimicrob Agents Chemother (1986) 1.33
RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother (2000) 1.31
Antimicrobial properties and mode of action of the pyrrothine holomycin. Antimicrob Agents Chemother (2001) 1.31
Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol (1980) 1.29
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Increased mutability of Pseudomonas aeruginosa in biofilms. J Antimicrob Chemother (2008) 1.20
Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1974) 1.20
Penicillin-binding protein 2 is required for induction of the Citrobacter freundii class I chromosomal beta-lactamase in Escherichia coli. Antimicrob Agents Chemother (1989) 1.20
Short-chain organic acids at ph 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J Appl Bacteriol (1991) 1.17
Effect of plasmid carriage on the virulence of staphylococcus aureus. J Med Microbiol (1975) 1.16
Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob Agents Chemother (1992) 1.13
Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother (1994) 1.09
Towards new business models for R&D for novel antibiotics. Drug Resist Updat (2011) 1.08
Induction of tetracycline resistance in Staphylococcus aureus in the absence of lipid synthesis. J Gen Microbiol (1975) 1.08
Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J Antimicrob Chemother (1986) 1.08
Expression of the Staphylococcus aureus UDP-N-acetylmuramoyl- L-alanyl-D-glutamate:L-lysine ligase in Escherichia coli and effects on peptidoglycan biosynthesis and cell growth. J Bacteriol (1999) 1.07
SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07
Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother (1992) 1.06
Distribution of fusidic acid resistance determinants in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2010) 1.06
Evidence for mutation to streptomycin resistance in clinical strains of Staphylococcus aureus. J Gen Microbiol (1972) 1.05
Lysozyme-promoted association of protein I molecules in the outer membrane of Escherichia coli. J Bacteriol (1977) 1.05
High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis. J Antimicrob Chemother (2008) 1.05
Genetic analysis of the tetA(C) gene on plasmid pBR322. J Bacteriol (1992) 1.01
Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies. J Antimicrob Chemother (2007) 1.01
Mutations affecting penicillin-binding proteins 2a, 2b and 3 in Bacillus subtilis alter cell shape and peptidoglycan metabolism. J Gen Microbiol (1987) 0.98
The antibacterial effects of low concentrations of antibiotics. Adv Microb Physiol (1986) 0.98
Accumulation of tetracyclines by Escherichia coli K-12. Biochem Biophys Res Commun (1977) 0.97
Stabilization of Rhizobium symbiosis plasmids. Microbiology (1999) 0.97
Energetics of tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1984) 0.93
Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities. Antimicrob Agents Chemother (2001) 0.91
Biochemical and genetic characterization of the tet determinant of Bacillus plasmid pAB124. J Bacteriol (1984) 0.90
Inhibition of Escherichia coli K12 by short-chain organic acids: lack of evidence for induction of the SOS response. J Appl Bacteriol (1991) 0.88
Antibacterial activity and mode of action of tert-butylhydroquinone (TBHQ) and its oxidation product, tert-butylbenzoquinone (TBBQ). J Antimicrob Chemother (2013) 0.87
Delayed postoperative intracerebral abscess caused by Proprionibacterium acnes: case report and review of the literature. Br J Neurosurg (2003) 0.87
Origin of tetracycline efflux proteins: conclusions from nucleotide sequence analysis. Mol Microbiol (1991) 0.86
Antibiotic resistance resulting from decreased drug accumulation. Br Med Bull (1984) 0.86
Limitations of a fluorescence assay for studies on tetracycline transport into Escherichia coli. Antimicrob Agents Chemother (1983) 0.84
Uptake of tetracycline by Escherichia coli is not mediated by the sodium dependent glutamate transport system. J Antimicrob Chemother (1990) 0.83
Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic. J Antimicrob Chemother (1993) 0.83
Outer membrane composition in Escherichia coli and the poor activity of hydrophobic antibiotics against enteric bacteria. J Antimicrob Chemother (1982) 0.83
Induction of the Citrobacter freundii group I beta-lactamase in Escherichia coli is not dependent on entry of beta-lactam into the cytoplasm. Antimicrob Agents Chemother (1990) 0.82
Use of mutator strains for characterization of novel antimicrobial agents. Antimicrob Agents Chemother (2001) 0.82
Intradural metastatic spinal cord compression from ACTH-secreting pituitary carcinoma. Acta Neurochir (Wien) (2004) 0.81
Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Mol Cell Endocrinol (1994) 0.81
Inhibition of beta-lactamase synthesis in Staphylococcus aureus by minocycline. J Antimicrob Chemother (1985) 0.80
Inhibition of Providencia stuartii cell envelope enzymes by chlorhexidine. J Antimicrob Chemother (1987) 0.80
Transcriptional signature following inhibition of early-stage cell wall biosynthesis in Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.80
Haemangioblastoma: a rare cause of a cerebellar mass in the elderly. Br J Neurosurg (2003) 0.79
Susceptibility of protein synthesis in Escherichia coli to tetracycline and minocycline. J Gen Microbiol (1981) 0.79
Lack of correlation between methicillin resistance and susceptibility to lysostaphin in Staphylococcus aureus. J Gen Microbiol (1974) 0.79
Genetic and biochemical basis of tetracycline resistance. J Antimicrob Chemother (1986) 0.78
Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule. J Antimicrob Chemother (1986) 0.78
Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections. Tuber Lung Dis (1998) 0.78
Tetracycline resistance in Escherichia coli K12 is not associated with a decrease in cyclopropane fatty acid content. J Gen Microbiol (1977) 0.77
Inhibition of K88-mediated adhesion of Escherichia coli to mammalian receptors by antibiotics that affect bacterial protein synthesis. J Antimicrob Chemother (1986) 0.77
Plasmid-determined tetracycline resistance in Escherichia coli K12: lack of evidence that resistance is related to changes in lipid metabolism [proceedings]. Biochem Soc Trans (1978) 0.77
An assay to detect inhibitors of bacterial iron transport. J Antibiot (Tokyo) (1994) 0.77
Triiodothyronine (T3) reflects renal graft function after renal transplantation. Clin Endocrinol (Oxf) (1997) 0.76
Pilocytic astrocytoma mimicking craniopharyngioma: a case series. Ann R Coll Surg Engl (2012) 0.75
Paradoxical response and tolerance in a strain of Staphylococcus aureus. J Antimicrob Chemother (1994) 0.75
Multiple isoelectric forms of bacterial penicillin-binding proteins: artefacts or genuine cellular components? J Antimicrob Chemother (1988) 0.75
Inhibition of K88ab-mediated haemagglutination by polymyxin B nonapeptide. J Antimicrob Chemother (1991) 0.75
Inhibition of staphylococcal growth by fusidic acid prevents production of volatile metabolites. J Antimicrob Chemother (2000) 0.75
Loose cilium in meibomian gland: mimicking early postoperative endophthalmitis. Eye (Lond) (2006) 0.75
Prediction of signal sequence-dependent protein translocation in bacteria: assessment of the Escherichia coli minicell system. Biochem Biophys Res Commun (1988) 0.75
Antibiotics and bacterial adhesion. J Antimicrob Chemother (1986) 0.75